Stay updated with breaking news from Mercy Bioanalytics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on "Global EV-based Liquid Biopsy Market Size, Share &...
Large for-profit life sciences companies have called Central Mass. their home for decades. Now, they play an important role in bringing talent, investment, and research to the region.
Mercy BioAnalytics, a life sciences company born in Cambridge and now based in Natick, has closed a $41 million Series A financing round.
Nearly 40 venture firms, from Andreessen Horowitz to Craft Ventures to Techstars, have accepted money from Saudi Arabia’s sovereign wealth fund.
The proceeds will help develop and commercialize its extracellular vesicle-based Mercy Halo platform for lung, ovarian, and other cancer screening tests.